Inari Medical Inc [NARI] stock prices are up 3.11% to $55.05 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NARI shares have gain 6.79% over the last week, with a monthly amount glided 7.12%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Inari Medical Inc [NASDAQ: NARI] stock has seen the most recent analyst activity on September 18, 2024, when Stifel initiated its Hold rating and assigned the stock a price target of $50. Previously, Leerink Partners started tracking the stock with Market Perform rating on September 03, 2024, and set its price target to $47. On August 09, 2024, Deutsche Bank initiated with a Buy rating and assigned a price target of $68 on the stock. William Blair started tracking the stock assigning a Outperform rating. Needham downgraded its rating to a Hold. Piper Sandler downgraded its rating to Neutral for this stock on February 29, 2024, and downed its price target to $55. In a note dated January 23, 2024, Needham initiated an Buy rating and provided a target price of $72 on this stock.
The stock price of Inari Medical Inc [NARI] has been fluctuating between $36.73 and $67.13 over the past year. Currently, Wall Street analysts expect the stock to reach $64 within the next 12 months. Inari Medical Inc [NASDAQ: NARI] shares were valued at $55.05 at the most recent close of the market. An investor can expect a potential return of 16.26% based on the average NARI price forecast.
Analyzing the NARI fundamentals
The Inari Medical Inc [NASDAQ:NARI] reported sales of 574.50M for trailing twelve months, representing a surge of 21.39%. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at -0.08%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.18 and Total Capital is -0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 53.53 points at the first support level, and at 52.02 for the second support level. However, for the 1st resistance point, the stock is sitting at 56.28, and for the 2nd resistance point, it is at 57.52.
Ratios To Look Out For
It’s worth pointing out that Inari Medical Inc [NASDAQ:NARI]’s Current Ratio is 1.77. In addition, the Quick Ratio stands at 1.40 and the Cash Ratio stands at 0.28. Considering the valuation of this stock, the price to sales ratio is 5.61, the price to book ratio is 7.40.
Transactions by insiders
Recent insider trading involved THOMAS TU, Officer, that happened on Dec 10 ’24 when 4000.0 shares were purchased. President and CEO, Hykes Andrew completed a deal on Nov 20 ’24 to sell 3000.0 shares. Meanwhile, Director Hoffman William sold 60000.0 shares on Nov 18 ’24.
